abnormal joint mobility_Tg(CAG-LacZ,-ACVR1*,-EGFP)35-1Mis/0

http://metadb.riken.jp/0008069IC57BL6DBA2TgCAGLacZACVR1EGFP351Mis0TgCAGLacZACVR1EGFP351Mis

abnormal joint mobility_Tg(CAG-LacZ,-ACVR1*,-EGFP)35-1Mis/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 35-1, Yuji Mishina
  http://metadb.riken.jp/db/mgi_rdf/MGI:3821883

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(CAG-LacZ,-ACVR1*,-EGFP)35-1Mis/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(CAG-LacZ,-ACVR1*,-EGFP)35-1Mis

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6 * DBA/2

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal joint mobility
  http://purl.obolibrary.org/obo/MP_0008069

文献

http://purl.org/net/cito/citesAsAuthority

• Paul B. Yu, et.al., BMP type I receptor inhibition reduces heterotopic [corrected] ossification., Nature medicine, 2008, 14
  http://rdf.ncbi.nlm.nih.gov/pubmed/19029982